首页 正文

[Tolerability and Outcome of Neoadjuvant GS Therapy for Resectable Pancreatic Cancer]

{{output}}
Introduction: Neoadjuvant chemotherapy with gemcitabine plus S-1(NAC GS)has been reported to prolong the prognosis of resectable pancreatic cancer, and is now being used in daily practice. In this study, we investigated the toler... ...